Expert Opinion on Drug Discovery

Show Articles
Journal Properties
  • Country
    United Kingdom
  • Language
    English
  • Number of Articles
    1,948
  • Abbreviation
    Expert Opin Drug Discovery
  • ISSN
    1746-0441
  • e-ISSN
    1746-045X
  • Main Publisher
    Taylor & Francis
  • Publisher
    Informa UK Limited
  • Indian UGC
  • DOAJ (latest)
Journal Properties
  • Medicine
    Public aspects of medicine
    Toxicology
    Poisons
    Medicine
    Therapeutics
    Pharmacology
  • website
Description
Expert Opinion on Drug Discovery offers insightful perspectives on emerging trends and novel technologies shaping the pharmaceutical landscape. It provides a platform for leading experts to share their views on the latest advancements in drug discovery, target validation, and therapeutic development. It is essential for professionals seeking expert commentary and forward-looking analysis in the drug discovery arena. The journal covers a broad range of topics, including high-throughput screening, genomics, proteomics, personalized medicine, and nanotechnology. It features review articles, commentaries, and perspectives from key opinion leaders. Expert Opinion on Drug Discovery is indexed in major databases and targets researchers, pharmaceutical scientists, and drug developers in academia and industry. Expert Opinion on Drug Discovery provides readers with actionable insights to drive innovation in pharmaceutical research and development. Authors are encouraged to submit manuscripts that offer unique viewpoints and stimulate discussion on the future of drug discovery. This journal is an important resource for staying ahead of emerging trends and maximizing therapeutic potential.